FleishmanHillard Welcomes Mary Kosinski as New Director

FleishmanHillard Enhances Their Leadership with Mary Kosinski

FleishmanHillard is pleased to announce the appointment of Mary Kosinski as the new Global Managing Director of Health and Life Sciences. In her new role, Kosinski will lead the agency's largest sector, focusing on driving transformation and delivering integrated solutions for clients in an ever-evolving healthcare landscape.

A Dynamic Addition to the Team

Mary Kosinski's appointment reflects her extensive background in regulatory policy and advocacy, making her a valuable asset to FleishmanHillard. Her previous role as head of global corporate affairs at Pi Health provided her with insights essential for navigating the complexities of healthcare communications. With over 15 years of experience in various public health advisory roles, including significant contributions to the U.S. Department of Health and Human Services, Kosinski is well-equipped to drive innovation and excellence within the sector.

Emphasis on Client Relationships

Mark Mortell, FleishmanHillard's global head of practices and sectors, emphasized that Mary's experience in government and public health will enhance their capability to serve clients effectively. This strong foundation aligns perfectly with FleishmanHillard's commitment to offering strategic counsel and support.

A Comprehensive Leadership Team

In conjunction with Kosinski's appointment, FleishmanHillard has announced three additional leadership roles within the Health and Life Sciences sector:

• John Gisborne has been appointed as the global head of strategic client partnerships, tasked with nurturing client relationships and identifying opportunities.
• Marc Longpre will take on the role of global head of strategy and insights for the sector, enhancing the agency's capabilities in key areas.
• Jenyne Engelhardt assumes the position of global head of operations and integration, focusing on improving efficiency and driving engagement.

These leaders bring a wealth of experience and will be integral in ensuring the sector meets the evolving needs of healthcare clients.

A Vision for the Future

Kosinski expressed her enthusiasm for joining FleishmanHillard, especially during this pivotal moment for the healthcare industry. With digital transformation, patient-centered care, and innovative therapeutics reshaping the landscape, Kosinski is committed to helping clients navigate these changes. FleishmanHillard's extensive experience in health and life sciences positions them uniquely to offer the support clients need to thrive.

Commitment to Excellence

FleishmanHillard's Health and Life Sciences team is dedicated to providing expert counsel across all facets of healthcare communications, including reputation management, product branding, public affairs, and crisis communications. The agency's continuous investment in leadership talent like Kosinski is a testament to its dedication to excellence in the field.

Following recent leadership changes, including J.J. Carter's appointment as president and CEO, this transformation within FleishmanHillard signals a robust response to the increasing need for sophisticated healthcare communication strategies.

About FleishmanHillard

FleishmanHillard specializes in various services such as public relations, digital strategies, and social engagement. They have received numerous accolades for their commitment to excellence, including multiple Campaign Global PR Agency of the Year titles and recognition from PRWeek.

About Omnicom PR Group

Omnicom PR Group (OPRG) represents the largest network of communications agencies globally, housing several top-tier PR agencies, including FleishmanHillard, Ketchum, and Porter Novelli. Their extensive reach and expertise empower them to handle complex communication needs in today’s fast-paced environment.

Frequently Asked Questions

Who is Mary Kosinski?

Mary Kosinski is the newly appointed Global Managing Director of Health and Life Sciences at FleishmanHillard, bringing extensive regulatory and healthcare experience.

What are the new leadership roles announced?

FleishmanHillard announced that John Gisborne, Marc Longpre, and Jenyne Engelhardt will assume significant roles in Health and Life Sciences alongside Mary Kosinski.

Why is Kosinski's appointment important?

Kosinski's experience in regulatory affairs and public health positions her to drive innovation and help clients navigate the evolving healthcare landscape.

What does FleishmanHillard specialize in?

FleishmanHillard specializes in public relations, reputation management, brand marketing, and digital strategy among other services.

What is the role of Omnicom PR Group?

Omnicom PR Group serves as the largest global network of communications agencies, encompassing multiple leading PR firms and specialist agencies.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.